OZ Recovery Technologies

Company Overview

Snapshot

Founded in January 1995, OZ Recovery Technologies operates with 1–10 employees. The company holds a patent for its technology, which is currently in the R&D product stage.

Business overview

OZ Recovery Technologies specializes in developing treatments for non-healing wounds. The company's core product, the Ozoter-101, is a device and methodology designed to administer an ozone-and-oxygen mixture directly to skin wounds. This technology targets the healthcare sector, specifically addressing conditions like diabetic ulcers and venous ulcers, and operates within the Health Tech & Life Sciences sector, focusing on medical devices and medical treatment & therapeutics.

Company Intelligence Q&A

What is the primary focus of OZ Recovery Technologies?

OZ Recovery Technologies focuses on developing treatments for non-healing wounds using a mixture of ozone and oxygen.

What is the Ozoter-101?

The Ozoter-101 is a device and methodology developed by OZ Recovery Technologies for administering an ozone-and-oxygen mixture directly to skin wounds, particularly for non-healing chronic wounds.

What is the reported success rate of the Ozoter-101?

Clinical studies have shown the Ozoter-101 to have a wound-healing success rate of over 80% for diabetic ulcers and venous ulcers.

In which sector does OZ Recovery Technologies primarily operate?

OZ Recovery Technologies primarily operates within the Health Tech & Life Sciences sector, with a focus on medical devices and medical treatment & therapeutics.

When was OZ Recovery Technologies founded?

OZ Recovery Technologies was founded in January 1995.